Pharmacists in Blackwood, New Jersey


13 Pharmacists found in Blackwood
female pharmacist

Clarita Hatley, PHARMD


Pharmacist
701 College Dr, Blackwood, NJ 08012
856-401-1191    

female pharmacist

Darlene Palermo


Pharmacist
625 N Black Horse Pike, Blackwood, NJ 08012
856-228-1368    

male pharmacist

Dr. Franklin S Breve, PHARMD, MBA


Pharmacist
6 Briarwood Dr, Blackwood, NJ 08012
856-566-1605     856-627-5292



male pharmacist

Jason Hyunjae Min, RPH


Pharmacist
625 N Black Horse Pike, Blackwood, NJ 08012
856-228-1368    

male pharmacist

Joseph E Olcese


Pharmacist
701 College Dr, Blackwood, NJ 08012
856-401-1191     856-401-9438

female pharmacist

Lealyza Cambaliza, RPH


Pharmacist - Pharmacotherapy
701 College Dr, Blackwood, NJ 08012
856-401-1191    

female pharmacist

Mona H Purohit


Pharmacist
625 N Black Horse Pike, Blackwood, NJ 08012
856-228-1368     856-228-1506

female pharmacist

Nirmita Patel


Pharmacist
625 N Black Horse Pike, Blackwood, NJ 08012
856-228-1368    

male pharmacist

Mr. Ralph J Yates, RPH


Pharmacist
249 Knoll Dr, Blackwood, NJ 08012
856-374-0117    

male pharmacist

Sean Lean Ngo, RPH


Pharmacist
2 S Black Horse Pike, Blackwood, NJ 08012
856-374-4602    

male pharmacist

Mr. Tony M Thanicatt, R.PH.


Pharmacist
625 N Black Horse Pike, Blackwood, NJ 08012
856-228-1368     856-228-1506

male pharmacist

Vinod I Patel, R.PH


Pharmacist
2 S Black Horse Pike, Blackwood, NJ 08012
856-374-4602     856-374-4693

female pharmacist

Yeana Kweon, RPH


Pharmacist
625 N Black Horse Pike, Blackwood, NJ 08012
856-228-1368     856-228-1506


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.